IKNA logo

Ikena Oncology (IKNA) Selling, General & Administrative Expenses

Annual SGA

$24.93 M
+$2.72 M+12.27%

December 31, 2023


Summary


Performance

IKNA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIKNAexpensesmetrics:

Quarterly SGA

$4.78 M
-$531.00 K-10.00%

September 30, 2024


Summary


Performance

IKNA Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIKNAexpensesmetrics:

TTM SGA

-$1.22 B
-$59.60 M-5.16%

September 30, 2024


Summary


Performance

IKNA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIKNAexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

IKNA Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.3%-20.8%-5739.3%
3 y3 years+181.1%-10.2%-5902.4%
5 y5 years+241.1%-10.2%-5902.4%

IKNA Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+38.4%-42.4%at low-121.6%at low
5 y5-yearat high+241.1%-42.4%+165.7%-991.9%at low
alltimeall timeat high+241.1%-42.4%+165.7%-991.9%at low

Ikena Oncology Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$4.78 M(-10.0%)
$24.38 M(-4.9%)
Jun 2024
-
$5.31 M(-11.5%)
$25.63 M(-0.1%)
Mar 2024
-
$6.00 M(-27.7%)
$25.65 M(+2.9%)
Dec 2023
$24.93 M(+12.3%)
$8.29 M(+37.4%)
$24.93 M(+15.6%)
Sep 2023
-
$6.03 M(+13.4%)
$21.56 M(+2.9%)
Jun 2023
-
$5.32 M(+0.9%)
$20.95 M(-2.4%)
Mar 2023
-
$5.28 M(+7.1%)
$21.47 M(-3.3%)
Dec 2022
$22.20 M
$4.92 M(-9.3%)
$22.20 M(-0.7%)
Sep 2022
-
$5.43 M(-7.1%)
$22.36 M(+2.5%)
Jun 2022
-
$5.84 M(-2.6%)
$21.83 M(+4.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
$6.00 M(+18.0%)
$20.84 M(+15.7%)
Dec 2021
$18.02 M(+103.2%)
$5.09 M(+4.0%)
$18.02 M(+15.2%)
Sep 2021
-
$4.89 M(+0.6%)
$15.64 M(+24.2%)
Jun 2021
-
$4.86 M(+53.2%)
$12.60 M(+32.1%)
Mar 2021
-
$3.17 M(+16.8%)
$9.53 M(+7.5%)
Dec 2020
$8.87 M(+21.3%)
$2.72 M(+47.3%)
$8.87 M(+44.1%)
Sep 2020
-
$1.84 M(+2.6%)
$6.15 M(+42.8%)
Jun 2020
-
$1.80 M(-28.4%)
$4.31 M(+71.6%)
Mar 2020
-
$2.51 M
$2.51 M
Dec 2019
$7.31 M
-
-

FAQ

  • What is Ikena Oncology annual SGA?
  • What is the all time high annual SGA for Ikena Oncology?
  • What is Ikena Oncology annual SGA year-on-year change?
  • What is Ikena Oncology quarterly SGA?
  • What is the all time high quarterly SGA for Ikena Oncology?
  • What is Ikena Oncology quarterly SGA year-on-year change?
  • What is Ikena Oncology TTM SGA?
  • What is the all time high TTM SGA for Ikena Oncology?
  • What is Ikena Oncology TTM SGA year-on-year change?

What is Ikena Oncology annual SGA?

The current annual SGA of IKNA is $24.93 M

What is the all time high annual SGA for Ikena Oncology?

Ikena Oncology all-time high annual SGA is $24.93 M

What is Ikena Oncology annual SGA year-on-year change?

Over the past year, IKNA annual SGA has changed by +$2.72 M (+12.27%)

What is Ikena Oncology quarterly SGA?

The current quarterly SGA of IKNA is $4.78 M

What is the all time high quarterly SGA for Ikena Oncology?

Ikena Oncology all-time high quarterly SGA is $8.29 M

What is Ikena Oncology quarterly SGA year-on-year change?

Over the past year, IKNA quarterly SGA has changed by -$1.26 M (-20.83%)

What is Ikena Oncology TTM SGA?

The current TTM SGA of IKNA is -$1.22 B

What is the all time high TTM SGA for Ikena Oncology?

Ikena Oncology all-time high TTM SGA is -$111.34 M

What is Ikena Oncology TTM SGA year-on-year change?

Over the past year, IKNA TTM SGA has changed by -$1.24 B (-5739.34%)